Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
Carril-Ajuria L, Desnoyer A, Meylan M, Dalban C, Naigeon M, Cassard L, Vano Y, Rioux-Leclercq N, Chouaib S, Beuselinck B, Chabaud S, Barros-Monteiro J, Bougoüin A, Lacroix G, Colina-Moreno I, Tantot F, Boselli L, De Oliveira C, Fridman WH, Escudier B, Sautes-Fridman C, Albiges L, Chaput-Gras N. Carril-Ajuria L, et al. J Immunother Cancer. 2022 May;10(5):e004885. doi: 10.1136/jitc-2022-004885. J Immunother Cancer. 2022. PMID: 35640928 Free PMC article. Clinical Trial.
Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use.
Bouet-Toussaint F, Patard JJ, Gervais A, Genetet N, de la Pintière CT, Rioux-Leclercq N, Toutirais O, Thirouard AS, Ramée MP, Catros-Quemener V. Bouet-Toussaint F, et al. Cancer Immunol Immunother. 2003 Nov;52(11):699-707. doi: 10.1007/s00262-003-0412-9. Epub 2003 Jul 15. Cancer Immunol Immunother. 2003. PMID: 12879292 Free PMC article. Clinical Trial.
[Renal cell carcinoma and prognostic factors].
Edeline J, Rioux-Leclercq N. Edeline J, et al. Ann Pathol. 2008 Oct;28(5):374-80. doi: 10.1016/j.annpat.2008.06.031. Epub 2008 Oct 4. Ann Pathol. 2008. PMID: 19068392 Free article. Review. French.
[Treatment of metastatic kidney cancer in elderly subjects].
Escudier B, Paparel P, Neuzillet Y, Long JA, Rioux-Leclercq N, Correas JM, Lang H, Poissonnier L, Baumert H, Mejean A, Patard JJ. Escudier B, et al. Prog Urol. 2009 Nov;19 Suppl 3:S129-32. doi: 10.1016/S1166-7087(09)73358-5. Prog Urol. 2009. PMID: 20123496 French.
Loss of expression of TIMP3 in clear cell renal cell carcinoma.
Masson D, Rioux-Leclercq N, Fergelot P, Jouan F, Mottier S, Théoleyre S, Bach-Ngohou K, Patard JJ, Denis MG. Masson D, et al. Eur J Cancer. 2010 May;46(8):1430-7. doi: 10.1016/j.ejca.2010.01.009. Epub 2010 Mar 1. Eur J Cancer. 2010. PMID: 20194016
PPARγ is functionally expressed in clear cell renal cell carcinoma.
Collet N, Théoleyre S, Rageul J, Mottier S, Jouan F, Rioux-Leclercq N, Fergelot P, Patard JJ, Masson D, Denis MG. Collet N, et al. Int J Oncol. 2011 Mar;38(3):851-7. doi: 10.3892/ijo.2010.891. Epub 2010 Dec 28. Int J Oncol. 2011. PMID: 21206970
295 results